Market Cap 93.08B
Revenue (ttm) 48.30B
Net Income (ttm) -8.95B
EPS (ttm) N/A
PE Ratio 7.05
Forward PE 7.28
Profit Margin -18.53%
Debt to Equity Ratio 2.81
Volume 17,893,900
Avg Vol 14,051,604
Day's Range N/A - N/A
Shares Out 2.04B
Stochastic %K 42%
Beta 0.33
Analysts Sell
Price Target $52.64

Company Profile

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 609 252 4621
Website: www.bms.com
Address:
Route 206 & Province Line Road, Princeton, United States
3DBuilds
3DBuilds Oct. 4 at 8:49 PM
0 · Reply
3DBuilds
3DBuilds Oct. 4 at 10:42 AM
$JNJ $LLY $BMY $PGHL.NSE $PFE The Future is here 💯 🌎 💰
0 · Reply
framus_morrigan
framus_morrigan Oct. 4 at 7:56 AM
$BMY Just for the record, the weekly chart. I expected for a better close but ... well , now that we let behind the ex-dividend date let's see next week.
0 · Reply
jheerdink
jheerdink Oct. 3 at 5:08 PM
$EPRX Eupraxia Pharmaceuticals Interest Surges With Craig-Hallum Price Target Boost, Clinical Milestones, and Pipeline Expansion -( $BMY ) https://vistapglobal.com/eupraxia-pharmaceuticals-interest-surges-with-craig-hallum-price-target-boost-clinical-milestones-and-pipeline-expansion-eprx-bmy-azn-sny/
0 · Reply
highnihilism
highnihilism Oct. 3 at 3:27 PM
$TGT Target Trades: 4,286 | Total $: 4.22 M | 0.08 × 90-Day Avg $: 50.63 M | Call $: 2.83 M | Put $: 1.39 M | Single-Leg: 72% | Multi-Leg: 28% $CELH Celsius Holdings Trades: 4,030 | Total $: 3.4 M | 0.41 × 90-Day Avg $: 8.37 M | Call $: 2.72 M | Put $: 672.3 K | Single-Leg: 90% | Multi-Leg: 10% $KTOS Kratos Defense & Security Trades: 1,109 | Total $: 3.21 M | 0.84 × 90-Day Avg $: 3.83 M | Call $: 2.7 M | Put $: 510.8 K | Single-Leg: 79% | Multi-Leg: 21% $BMY Bristol-Myers Squibb Trades: 3,063 | Total $: 3.49 M | 0.46 × 90-Day Avg $: 7.51 M | Call $: 2.66 M | Put $: 823.6 K | Single-Leg: 78% | Multi-Leg: 22%
0 · Reply
FallingKnifeVictim
FallingKnifeVictim Oct. 3 at 3:17 PM
$BMY 5k shares large, at lows yesterday and today, score!!! LFG contrarians!
0 · Reply
Nullify
Nullify Oct. 3 at 2:56 PM
$BMY they getting this ready to run
1 · Reply
StrategicBankruptcies
StrategicBankruptcies Oct. 3 at 2:47 PM
$BMY nice 👍
0 · Reply
SniperPro
SniperPro Oct. 3 at 2:34 PM
$LXRX $NVO $BMY $VTRS $PFE We’ve got so many positive catalysts ahead! Don’t forget: SOTA USA/EU partner LX9211 partner And who knows what other molecules they’re negotiating behind the scenes—only God knows. The NVO deal came out of nowhere; even I was caught by surprise. At this point, shorting this low is a risky move—anything can happen. MAHA + FDA are not messing around, and this administration knows too many good drugs have been left on the back burner for far too long. 💥 The tide is turning.
1 · Reply
scientificway
scientificway Oct. 3 at 2:10 PM
$BMY buy low. NAGE, no debt, guidance up. quick bounce
0 · Reply
Latest News on BMY
Final Trade: GDX, PFE, GFS, BMY

Oct 1, 2025, 6:32 PM EDT - 2 days ago

Final Trade: GDX, PFE, GFS, BMY

GDX GFS PFE


Bristol Myers to sell psoriasis drug at over 80% discount

Sep 25, 2025, 7:08 AM EDT - 9 days ago

Bristol Myers to sell psoriasis drug at over 80% discount


Buy Bristol Myers Squibb Stock At $45?

Sep 23, 2025, 6:55 AM EDT - 11 days ago

Buy Bristol Myers Squibb Stock At $45?


Bristol Myers Squibb Announces Dividend

Sep 17, 2025, 6:59 AM EDT - 17 days ago

Bristol Myers Squibb Announces Dividend


Bristol Myers to sell 60% stake in China joint venture

Sep 17, 2025, 12:04 AM EDT - 17 days ago

Bristol Myers to sell 60% stake in China joint venture


Bristol-Myers Squibb: Why Q2 Results Signal A Turning Point

Sep 8, 2025, 9:47 AM EDT - 26 days ago

Bristol-Myers Squibb: Why Q2 Results Signal A Turning Point


Bristol-Myers Squibb: Buy Before The Market Realizes Its Folly

Sep 5, 2025, 11:30 AM EDT - 4 weeks ago

Bristol-Myers Squibb: Buy Before The Market Realizes Its Folly


Bristol-Myers Squibb: Not As Cheap As It Might Seem

Sep 3, 2025, 5:56 PM EDT - 4 weeks ago

Bristol-Myers Squibb: Not As Cheap As It Might Seem


7 Big Yields From The Beat-Up Healthcare Sector

Sep 1, 2025, 10:52 AM EDT - 4 weeks ago

7 Big Yields From The Beat-Up Healthcare Sector

DOC LTC OHI PFE SIGA SILA


Final Trades: ServiceNow, Bristol Myers and Live Nation

Aug 21, 2025, 2:20 PM EDT - 6 weeks ago

Final Trades: ServiceNow, Bristol Myers and Live Nation

LYV NOW


3 SWANs On Sale

Aug 8, 2025, 7:00 AM EDT - 2 months ago

3 SWANs On Sale

ELV REXR


3 Dividend Stocks for August 2025

Aug 5, 2025, 11:01 AM EDT - 2 months ago

3 Dividend Stocks for August 2025

AMGN POR


Bristol-Myers Squibb: Buy The Weakness

Aug 4, 2025, 6:03 AM EDT - 2 months ago

Bristol-Myers Squibb: Buy The Weakness


Bristol-Myers Squibb: Declines Have Gone Too Far

Aug 2, 2025, 10:42 AM EDT - 2 months ago

Bristol-Myers Squibb: Declines Have Gone Too Far


3DBuilds
3DBuilds Oct. 4 at 8:49 PM
0 · Reply
3DBuilds
3DBuilds Oct. 4 at 10:42 AM
$JNJ $LLY $BMY $PGHL.NSE $PFE The Future is here 💯 🌎 💰
0 · Reply
framus_morrigan
framus_morrigan Oct. 4 at 7:56 AM
$BMY Just for the record, the weekly chart. I expected for a better close but ... well , now that we let behind the ex-dividend date let's see next week.
0 · Reply
jheerdink
jheerdink Oct. 3 at 5:08 PM
$EPRX Eupraxia Pharmaceuticals Interest Surges With Craig-Hallum Price Target Boost, Clinical Milestones, and Pipeline Expansion -( $BMY ) https://vistapglobal.com/eupraxia-pharmaceuticals-interest-surges-with-craig-hallum-price-target-boost-clinical-milestones-and-pipeline-expansion-eprx-bmy-azn-sny/
0 · Reply
highnihilism
highnihilism Oct. 3 at 3:27 PM
$TGT Target Trades: 4,286 | Total $: 4.22 M | 0.08 × 90-Day Avg $: 50.63 M | Call $: 2.83 M | Put $: 1.39 M | Single-Leg: 72% | Multi-Leg: 28% $CELH Celsius Holdings Trades: 4,030 | Total $: 3.4 M | 0.41 × 90-Day Avg $: 8.37 M | Call $: 2.72 M | Put $: 672.3 K | Single-Leg: 90% | Multi-Leg: 10% $KTOS Kratos Defense & Security Trades: 1,109 | Total $: 3.21 M | 0.84 × 90-Day Avg $: 3.83 M | Call $: 2.7 M | Put $: 510.8 K | Single-Leg: 79% | Multi-Leg: 21% $BMY Bristol-Myers Squibb Trades: 3,063 | Total $: 3.49 M | 0.46 × 90-Day Avg $: 7.51 M | Call $: 2.66 M | Put $: 823.6 K | Single-Leg: 78% | Multi-Leg: 22%
0 · Reply
FallingKnifeVictim
FallingKnifeVictim Oct. 3 at 3:17 PM
$BMY 5k shares large, at lows yesterday and today, score!!! LFG contrarians!
0 · Reply
Nullify
Nullify Oct. 3 at 2:56 PM
$BMY they getting this ready to run
1 · Reply
StrategicBankruptcies
StrategicBankruptcies Oct. 3 at 2:47 PM
$BMY nice 👍
0 · Reply
SniperPro
SniperPro Oct. 3 at 2:34 PM
$LXRX $NVO $BMY $VTRS $PFE We’ve got so many positive catalysts ahead! Don’t forget: SOTA USA/EU partner LX9211 partner And who knows what other molecules they’re negotiating behind the scenes—only God knows. The NVO deal came out of nowhere; even I was caught by surprise. At this point, shorting this low is a risky move—anything can happen. MAHA + FDA are not messing around, and this administration knows too many good drugs have been left on the back burner for far too long. 💥 The tide is turning.
1 · Reply
scientificway
scientificway Oct. 3 at 2:10 PM
$BMY buy low. NAGE, no debt, guidance up. quick bounce
0 · Reply
Walnuts86
Walnuts86 Oct. 3 at 2:09 PM
$BMY oddest behavior. Spikes 2 days before ex div. Crashes day before. Rises day of. What kind of lala land we in here
3 · Reply
Mc0731
Mc0731 Oct. 3 at 1:19 PM
$BMY Triple bottom in last 5 months, is she trying for a 4th?
0 · Reply
stocksuck
stocksuck Oct. 3 at 1:15 PM
$BMY let’s get this over 50
0 · Reply
stocksuck
stocksuck Oct. 3 at 10:06 AM
$BMY all the stupid people keep chasing sky high tech while ignore these keep health stocks that everyone needs for life
1 · Reply
StrategicBankruptcies
StrategicBankruptcies Oct. 3 at 9:44 AM
$BMY Bought yesterday for all portfolios. Forward PE 7. Nice dividend.
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 6:01 AM
$BMY: Unusual Options Activity Alerted CALL flow observed 200x contracts at Strike price of $50 Exp on 11/21/2025 with Premium of $27K and showing NEUTRAL Sentiment
0 · Reply
StockAutoPro
StockAutoPro Oct. 3 at 3:40 AM
$BMY: Buy target $43.73 Sell target $48.02 Pharmaceutical sector showing strong resilience; consider diversifying portfolio with leading immunotherapy drug producer.
0 · Reply
Shanghi18
Shanghi18 Oct. 2 at 11:19 PM
$BMY in 45.85. 2/3 stake. Betting it bounces Despite exdate
1 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:04 PM
0 · Reply
EmbraceVolatility
EmbraceVolatility Oct. 2 at 11:03 PM
$BMY Make a deal with Trump and it's PFE 2.0. BMY and MRK are next. Even though the deal is just fluff. No impact on bottom line.
0 · Reply
john116868
john116868 Oct. 2 at 9:49 PM
$BMY well they added the dip
0 · Reply
JRquiz
JRquiz Oct. 2 at 9:37 PM
$BMY Just a reminder: If you buy anytime tomorrow, you get the divi. If you buy on Monday, no divi.
2 · Reply